modelTapentadol_Watson2019_reference

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral.

Information

name:tapentadol
ATC code:N02AX06
model:one compartment, oral dosing (PK_1C_enteral)
source:Watson E et al. 2019
population:pediatric patients (2 to <18 years)
measured compound:tapentadol
review:accepted with caveats
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
CL/F (L/h)170L/hCL/F
V/F (L)685LV/F
Ka (h−1)2.03h−1kabs
TLAG (h)0.247htlag
theta_q319_wt_power0.638equation variable
theta_q319_wt_power0.847equation variable

About tapentadol

Tapentadol is an opioid painkiller used to treat moderate to severe pain, including pain associated with fibromyalgia. It is an approved medicine and is widely used as an analgesic, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q414463 and the WHO ATC classification; not checked by a person.

Identity, molar mass and metabolites: Tapentadol.

References

  1. Watson E et al. (2019). Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population. Journal of pain research 12:2835–2850. DOI:10.2147/JPR.S208454 PUBMED:31686902

Parameters

TypeNameDefaultDescription
RealCl_ref4.722222222222223e-05Cl [m3/s]
RealVd_ref0.685Vd [m3]
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.TransferRateka (from PK_1C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_1C_enteral)600delay between oral administration and absorption (default 10min)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Watson_2019: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: accepted with caveats